4D Biomaterials Revenue and Competitors

Nottingham,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • 4D Biomaterials's estimated annual revenue is currently $1.5M per year.(i)
  • 4D Biomaterials's estimated revenue per employee is $125,500

Employee Data

  • 4D Biomaterials has 12 Employees.(i)
  • 4D Biomaterials grew their employee count by 0% last year.

4D Biomaterials's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head R&D OperationsReveal Email/Phone
3
Product Development ScientistReveal Email/Phone
4
Production ChemistReveal Email/Phone
5
Production EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is 4D Biomaterials?

The market for polymeric biomaterials is growing quickly, but despite this growth, it is widely recognised in the industry that the ‘holy grail’ solution has not yet been developed. The ideal biomaterial for use in regenerative medicine must: be biocompatible; promote tissue regeneration; have non-toxic biodegradation, have mechanical properties suited to the host tissue and good handling properties in a clinical environment. Our people have developed a patented range of novel polymeric 3-D printing resin-inks that promise, uniquely, to meet all of the above requirements and offer important advantages over the next best alternatives. The polymers and their degradation products are non-toxic and their properties can be tuned to suit a wide range of tissue regeneration applications. These 3-D printable resin-inks will enable medical implants to be fitted to the exact shape and dimensional requirements of each patient, optimising outcomes in applications such as cancer treatment, degenerative spinal conditions and reconstructive surgery. Initial in-vitro and in-vivo testing has provided strong evidence of the anticipated biocompatibility and tissue regeneration properties that will enable multiple stakeholders in the health sector to benefit from improved treatment options for a range of life-changing conditions, not least the patients themselves.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

4D Biomaterials News

2022-04-13 - 4D Materials Design and Additive Manufacturing Conference ...

New materials, design, and functionalities (digital materials, auxetics, lattices, metamaterials, smart materials in robotics, biomaterials, 3D/4D-printed...

2022-04-13 - 4DMDA conference takes a deeper look at 4D materials for AM

... biomaterials, 3D/4D-printed soft robots), advanced additive manufacturing techniques of smart materials (4D printing, bioprinting,...

2022-03-22 - Interview: 4D Biomaterials - "You couldn't make it in any other way other than 3D printing.”

Interview: 4D Biomaterials - "You couldn't make it in any other way other than 3D printing.” "We've got, potentially, a world-beating material.".

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.8M120%N/A
#2
$2.4M12-8%N/A
#3
$1M12N/AN/A
#4
$1.6M13-24%N/A
#5
$3M15-17%N/A